Eradication of Helicobacter pylori Infection by the Probiotic Strains Lactobacillus johnsonii MH-68 and L. salivarius ssp. salicinius AP-32

Helicobacter

Volumn 17, Issue 6, 2012, Pages 466-477

  Hsieh, Pei Shan ^a,b   Tsai, Yi Chun ^b   Chen, Yi Chun ^b   Teh, Su Fen ^a   Ou, Chung Mou ^a   King, V An Erl ^a  

^a NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^b Glac Biotech Co Ltd   (Taiwan)

Author keywords

Helicobacter pylori; Lactic acid bacteria; Lactobacillus; Probiotic; Urease activity

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 8; PROBIOTIC AGENT; UREASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERICIDAL ACTIVITY; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME ACTIVITY; ERADICATION THERAPY; GROWTH INHIBITION; HELICOBACTER INFECTION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS JOHNSONII; LACTOBACILLUS SALIVARIUS; LIQUID CULTURE; LYMPHOCYTIC INFILTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STOMACH ACID; STOMACH MUCOSA;

ADULT; ANIMALS; ANTIBIOSIS; BACTERIAL ADHESION; BACTERIAL LOAD; CELL LINE; DISEASE MODELS, ANIMAL; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INFANT; INTERLEUKIN-10; INTERLEUKIN-8; LACTOBACILLUS; MALE; MICE; MILK, HUMAN; PROBIOTICS; RATS; RATS, SPRAGUE-DAWLEY; TAIWAN; TREATMENT OUTCOME; VAGINA;

EID: 84867695562     PISSN: 10834389     EISSN: 15235378     Source Type: Journal    
DOI: 10.1111/j.1523-5378.2012.00992.x     Document Type: Article

References (46)

1. Marshall BJ, Warren JR. The bacterium Helicobacter pylori and its role in gastritis and peptic ulcer disease. The Nobel Prize in Physiology or Medicine 2005.
2. Malfertheiner P, Megraud F, O'Morain C, Bazzoli F, El-Omar E, Graham D, Hunt R, Rokkas T, Vakil N, Kuipers EJ. Current concepts in the management of Helicobacter pyIori infection: the Maastricht III Consensus Report. Gut 2007;56:772-81.
3. Nord CE, Heimdal A, Kager L. Antimicrobial induced alterations of the human oropharyngeal and intestinal microflora. Scand J Infect Dis 1986;49:64-72.
4. Adamsson I, Nord CE, Lundquist P, Sjöstedt S, Edlund C. Comparative effects of omeprazole, amoxycillin, plus metronidazole versus omeprazole, clarithromycin plus metronidazole on the oral, gastric and intestinal microflora in Helicobacter pylori-infected patients. J Antimicrob Chemother 1999;44:629-40.
5. Sachdeva A, Nagpal J. Effect of fermented milk-based probiotic preparations on Helicobacter pylori eradication: a systematic review and meta-analysis of randomized-controlled trials. Eur J Gastroenterol Hepatol 2009;21:45-53.
6. Velázquez M, Feirtag JM. Helicobacter pylori: characteristics, pathogenicity, detection methods and mode of transmission implicating foods and water. Int J Food Microbiol 1999;53:95-104.
7. Makristathis A, Rotika E, Labigne A, Willinger B, Rotter ML, Hirschl AM. Highly significant role of Helicobacter pylori urease in phagocytosis and production of oxygen metabolites by human granulocytes. J Infect Dis 1998;177:803-6.
8. Marshall BJ, Barret LJ, Prakash C, McCallum RW, Guerrant RL. Urea protects Helicobacter (Campylobacter) pylori from the bactericidal effect of acid. Gastroenterology 1990;99:697-702.
9. Nakamura H, Yoshiyama H, Takeuchi H, Mizote T, Okita K, Nakazawa T. Urease plays an important role in the chemotactic motility of Helicobacter pylori in a viscous environment. Infect Immun 1998;66:4832-7.
10. Suzuki M, Miura S, Suematsu M, Fukumura D, Kurose I, Suzuki H, Kai A, Kudoh Y, Ohashi M, Tsuchiya M. Helicobacter pylori associated ammonia production enhances neutrophil-dependent gastric mucosal cell injury. Am J Physiol 1992;263:G719-25.
11. Kuwahara H, Miyamoto Y, Akaike T, Kubota T, Sawa T, Okamoto S, et al. Helicobacter pylori urease suppresses bactericidal activity of peroxynitrite via carbon dioxide production. Infect Immun 2000;68:4378-83.
12. Sgouras D, Maragkoudakis P, Petraki K, Martinez-Gonzalez B, Eriotou E, Michopoulos S, et al. In vitro and in vivo inhibition of Helicobacter pylori by Lactobacillus casei strain Shirota. Appl Environ Microbiol 2004;70:518-26.
13. Hazell SL, Borody TJ, Gal A, Lee A. Campylobacter pyloridis gastritis. I. Detection of urease as a marker of bacterial colonization and gastritis. Am J Gastroenterol 1987;82:292-6.
14. Strus M, Kucharska A, Kukla G, Brzychczy-Wloch M, Maresz K, Heczko PB. The in vitro activity of vaginal Lactobacillus with probiotic properties against Candida. Infect Dis Obstet Gynecol 2005;13:69-75.
15. Shmuely H, Burger O, Neeman I, Yahav J, Samra Z, Niv Y, et al. Susceptibility of Helicobacter pylori isolates to the antiadhesion activity of a high-molecular-weight constituent of cranberry. Diagn Microbiol Infect Dis 2004;50:231-5.
16. Rokka S, Myllykangas S, Joutsjoki V. Effect of specific colostral antibodies and selected Lactobacilli on the adhesion of Helicobacter pylori on AGS cells and the Helicobacter-induced IL-8 production. Scand J Immunol 2008;68:280-6.
17. Chen X, Liu XM, Tian F, Zhang Q, Zhang HP, Zhang H, Chen W. Antagonistic activities of Lactobacilli against Helicobacter pylori growth and infection in human gastric epithelial cells. J Food Sci 2012;71:M9-14.
18. Shay H, Komarov SA, Fels SE, Meraze D, Gruenstein M, Siplet H. A simple method for the uniform production of gastric ulceration in the rat. Gastroenterology 1945;5:43-61.
19. Khandare RA, Gulecha VS, Mahajan MS. Evaluation of antiulcer activity polyherbal formulation. Int J Pharma Res Dev 2009;1:1-6.
20. Svedlund J, Sjodin I, Dotevall G. GSRS: a clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease. Dig Dis Sci 1988;33:129-34.
21. Cui Y, Wang CL, Liu XW, Wang XH, Chen LL, Zhao X, Fu N, Lu FG. Two stomach-originated lactobacillus strains improve Helicobacter pylori infected murine gastritis. World J Gastroenterol 2010;28:445-52.
22. Min K, Hong SM, Kim KR, Ro JY, Park MJ, Kim JS, Kim JM, Jung HC, Yu E. IntramucosaI Helicobacter pylori in the human and murine stomach: its relationship to the inflammatory reaction in human Helicobacter pylori gastritis. Pathol Res Pract 2003;199:1-8.
23. Wang XI, Zhang S, Abreo F, Thomas J. The role of routine immunohistochemistry for Helicobacter pylori in gastric biopsy. Ann Diagn Pathol 2010;14:256-9.
24. Myllyluoma E. The Role of Probiotics in Helicobacter pylori Infection. Helsinki University, Helsinki, Finland: Foundation for Nutrition Research Press, 2007;1-86.
25. Lin JT, Wang JT, Wang TH, Wu MS, Lee TK, Chen CJ. Helicobacter pylori infection in a randomly selected population, healthy volunteers, and patients with gastric ulcer and gastric adenocarcinoma. A seroprevalence study in Taiwan. Scand J Gastroenterol 1993;28:1067-72.
26. Zou J, Dong J, Yu X. Meta-analysis: Lactobacillus containing quadruple therapy versus standard triple first-line therapy for Helicobacter pylori eradication. Helicobacter 2009;14:449-59.
27. Kim MN, Kim N, Lee SH, et al. The effect of probiotics on PPI-triple therapy for Helicobacter pylori eradication. Helicobacter 2008;13:261-8.
28. Ki MR, Goo MJ, Park JK et al. Helicobacter pylori accelerates hepatic fibrosis by sensitizing transforming growth factor-b1-induced inflammatory signaling. Lab Invest 2010;90:1507-16.
29. Aiba Y, Suzuki N, Kabir AM, Takagi A, Koga Y. Lactic acid mediated suppression of Helicobacter pylori by the oral administration of Lactobacillus salivarius as a probiotic in a gnotobiotic murine model. Am J Gastroenterol 1998;93:2097-101.
30. Collado MC, González A, Gonzalez R, Hernandez M, Ferrus MA, Sanz Y. Antimicrobial peptides are among the antagonistic metabolites produced by Bifidobacterium against Helicobacter pylori. Int J Antimicrob Agents 2005;25:385-91.
31. Francavilla R, Lionetti E, Castellaneta SP, Magistà AM, Maurogiovanni G, Bucci N, et al. Inhibition of Helicobacter pylori infection in humans by Lactobacillus reuteri ATCC 55730 and effect on eradication therapy: a pilot study. Helicobacter 2008;13:127-34.
32. Conway PL, Gorbach SL, Goldin BR. Survival of lactic acid bacteria in the human stomach and adhesion to intestinal cells. J Dairy Sci 1987;70:1-12.
33. Tomas MSJ, Bru E, Nader-Macias MEF. Estimation of combined effects of carbon and nitrogen sources on the growth and bacteriocin production of Lactobacillus salivarius from human source. J Basic Microbiol 2010;50:190-9.
34. Prasanthi CH, Prasanthi NL, Manikiran SS, Rao NR. Focus on current trends in the treatment of Helicobacter pylori infection: an update. Int J Pharma Sci Rev Res 2011;9:42-51.
35. Jack RW, Tagg JR, Ray B. Bacteriocins of gram-positive bacteria. Microbiol Rev 1995;59:171-200.
36. Gotteland M, Andrews M, Toledo M, Muñoz L, Caceres P, Anziani A, et al. Modulation of Helicobacter pylori colonization with cranberry juice and Lactobacillus johnsonii La1 in children. Nutrition 2008;24:421-6.
37. Michetti P, Dorta G, Wiesel PH. Effect of whey-based culture supernatant of Lactobacillus acidophilus (johnsonii) La1 on Helicobacter pylori infection in humans. Digestion 1999;60:203-9.
38. Cataloluk O, Gurakan CG. Characterization of salivaricin B, A protein expressed by Lactobacillus salivarius M7. Turk J Biol 2003;27:131-6.
39. Lewis SJ, Freedman AR. Review article: the use of biotherapeutic agents in the prevention and treatment of gastrointestinal disease. Aliment Pharmacol Ther 1998;12:807-22.
40. Smoot DT. How does Helicobacter pylori cause mucosal damage? Direct mechanisms. Gastroenterology 1997;113:S31-4.
41. Kabir AM, Aiba Y, Takagi A, Kamiya S, Miwa T, Koga Y. Prevention of Helicobacter pylori infection by lactobacilli in a gnotobiotic murine model. Gut 1997;41:49-55.
42. Nam H, Ha M, Bae O, Lee Y. Effect of Weissella confusa strain PL9001 on the adherence and growth of Helicobacter pylori. Appl Environ Microbiol 2002;68:4642-5.
43. Marteau P, Rambaud JC. Potential of using lactic acid bacteria for therapy and immunomodulation in man. FEMS Microbiol Rev 1993;12:207-20.
44. Byrd JC, Yunker CK, Xu QS, Sternberg LR, Bresalier RS. Inhibition of gastric mucin synthesis by Helicobacter pylori. Gastroenterology 2000;118:1072-9.
45. Mack DR, Ahrne S, Hyde L, Wei S, Hollingsworth MA. Extracellular MUC3 mucin secretion follows adherence of Lactobacillus strains to intestinal epithelial cells in vitro. Gut 2003;52:827-33.
46. Vuyst LD, Leroy F. Bacteriocins from lactic acid bacteria: production, purification, and food applications. J Mol Microbiol Biotechnol 2007;13:194-9.